Comparison of biochemical markers and technetium 99m methoxyisobutylisonitrile imaging in primary and secondary hyperparathyroidism.

Wang, Yuhua; Liu, Ye; Li, Na; Zhang, Wanchun

Wang, Yuhua; Liu, Ye; Li, Na; Zhang, Wanchun.

Afiliación

Wang Y; Department of Nuclear Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
Liu Y; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li N; Department of Nuclear Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
Zhang W; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Front Endocrinol (Lausanne) ; 14: 1094689, 2023.

Article en En | MEDLINE | ID: mdl-37051197

Asunto(s)

Hiperparatiroidismo Secundario; Neoplasias de las Paratiroides; Humanos; Neoplasias de las Paratiroides/cirugía; Hiperplasia; Tecnecio Tc 99m Sestamibi; Hiperparatiroidismo Secundario/diagnóstico por imagen; Hiperparatiroidismo Secundario/etiología; Hiperparatiroidismo Secundario/patología; Biomarcadores

Palabras clave

SPECT/CT fusion imaging; parathyroid adenoma; parathyroid hyperplasia; primary hyperparathyroidism; secondary hyperparathyroidism; technetium Tc 99m sestamibi

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de las Paratiroides / Hiperparatiroidismo Secundario Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google